Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC

Clinical trial NCT03177291 · COMPLETED

Trial details

NCT number: NCT03177291
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Non Small Cell Lung Cancer Advanced Cancer Metastatic Lung Cancer Squamous Cell Lung Cancer Non-Squamous Non-Small Cell Neoplasm of Lung

Start date: 2017-09-26
Primary completion: 2021-05-09
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.